Yayın:
Synthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors

dc.contributor.authorKurban, Berkant
dc.contributor.authorOSMANİYE, DERYA
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorLEVENT, SERKAN
dc.contributor.authorKAPLANCIKLI, ZAFER ASIM
dc.contributor.orcid0000-0002-1595-3870
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0003-3692-163X
dc.contributor.orcid0000-0001-8815-153X
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2025-11-13T09:11:46Z
dc.date.issued2023-08-17
dc.identifier.doihttps://doi.org/10.1021/acsomega.3c04635
dc.identifier.endpage31509
dc.identifier.issn2470-1343
dc.identifier.issue34
dc.identifier.openalexW4385918066
dc.identifier.startpage31500
dc.identifier.urihttps://hdl.handle.net/11421/734
dc.identifier.urihttps://doi.org/10.1021/acsomega.3c04635
dc.identifier.volume8
dc.language.isoen
dc.relation.ispartofACS Omega
dc.rightsopenAccess
dc.subjectCytotoxicity
dc.subjectPyrazole
dc.subjectIC50
dc.subjectEpidermal growth factor receptor
dc.subjectFlow cytometry
dc.subjectChemistry
dc.subjectEGFR inhibitors
dc.subjectDocking (animal)
dc.subjectLung cancer
dc.subjectPharmacology
dc.subjectIn vitro
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectStereochemistry
dc.subjectMolecular biology
dc.subjectReceptor
dc.subjectMedicine
dc.subjectOncology
dc.subject.sdg3
dc.titleSynthesis and Anticancer Activities of Pyrazole–Thiadiazole-Based EGFR Inhibitors
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5040463215
local.authorid.openalexA5017640266
local.authorid.openalexA5030511747
local.authorid.openalexA5074136342
local.authorid.openalexA5075534569
local.authorid.openalexA5060247565

Dosyalar

Koleksiyonlar